GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve 1. the Unaudited Financial Results ....
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GPT Healthcare has informed the stock exchanges that its Board of Directors will meet on Saturday, November 8, 2025. The Board will consider and approve the Unaudited Financial Results (along with the Limited Review Report from statutory auditors) for the second quarter and half year ended September 30, 2025. The Board will also consider the declaration of a first interim dividend for FY 2025-26, if any. The trading window for the company's securities remains closed until November 10, 2025, to prevent insider trading ahead of the results announcement.
Investors should watch for the Q2 FY26 earnings release on or after November 8, which could move the stock price. The possible interim dividend declaration is a positive signal for shareholders looking for income from the stock.